Rogers Matthew, Vangaveti Venkat, Ireland Susan, Puvvadi Ramaa
Department of Paediatric Medicine, Townsville University Hospital, Townsville, Queensland, Australia.
Townsville Institute of Health Research and Innovation, Townsville University Hospital, Townsville, Queensland, Australia.
J Paediatr Child Health. 2025 Mar;61(3):433-440. doi: 10.1111/jpc.16765. Epub 2025 Jan 7.
To study the demographic characteristics, risk factors, management details and clinical outcomes to 12 months corrected age in indigenous and non-indigenous infants with chronic neonatal lung disease in North Queensland.
Retrospective cohort study of infants with chronic neonatal lung disease admitted to a tertiary neonatal intensive care unit in regional Queensland from January 2015 to December 2019.
There were 139 infants with chronic neonatal lung disease and 425 controls. The incidence of chronic neonatal lung disease in infants born at < 33 weeks gestational age was 32.6% versus 20.4% in indigenous and non-indigenous infants, respectively (OR 1.8, p value 0.001). Indigenous infants had significantly lower birth weight (830 g vs. 1000 g, p value 0.039), higher rate of maternal smoking during the pregnancy (57.4% vs. 25%, p value < 0.001), were less likely to be inborn (71.4% vs. 88.2%, p value 0.017) or receive adequate course of antenatal corticosteroids (30.2% vs. 59.2%, p value < 0.001), had increased incidence of grade 2 intraventricular haemorrhage (17.5% vs. 4%, p value 0.01) and were more likely to reside in a very remote locality (17.4% vs. 3.9%, p < 0.001). Identified risk factors for chronic neonatal lung disease included lower birth weight (OR 0.99, p value 0.014), lower birth gestation (OR 1.57, p value 0.003), longer duration of continuous positive airway pressure (OR 1.004, p value < 0.001), longer duration of humidified high-flow nasal prongs (OR 1.003, p < 0.001), doses of surfactant (OR 1.55, p value 0.038) and receiving post-natal steroids (OR 19.03, p < 0.001). There were no other significant differences in comorbidities, management, complications, number of hospital admissions or weight to 12-months corrected age.
Indigenous infants had increased antenatal risk factors for chronic neonatal lung disease and account for a disproportionate number of cases, however, their outcomes to 12 months corrected age were similar to non-indigenous infants.
研究北昆士兰地区患有慢性新生儿肺病的原住民和非原住民婴儿的人口统计学特征、风险因素、管理细节及至矫正年龄12个月时的临床结局。
对2015年1月至2019年12月期间入住昆士兰地区一家三级新生儿重症监护病房的患有慢性新生儿肺病的婴儿进行回顾性队列研究。
共有139例患有慢性新生儿肺病的婴儿和425例对照。孕周<33周出生的婴儿中,慢性新生儿肺病的发病率在原住民和非原住民婴儿中分别为32.6%和20.4%(比值比1.8,p值0.001)。原住民婴儿出生体重显著更低(830克对1000克,p值0.039),孕期母亲吸烟率更高(57.4%对25%,p值<0.001),更不可能为足月儿(71.4%对88.2%,p值0.017)或接受足够疗程的产前皮质类固醇治疗(30.2%对59.2%,p值<0.001),2级脑室内出血发生率增加(17.5%对4%,p值0.01),且更可能居住在极偏远地区(17.4%对3.9%,p<0.001)。确定的慢性新生儿肺病风险因素包括出生体重较低(比值比0.99,p值0.014)、出生孕周较小(比值比1.57,p值0.003)、持续气道正压通气时间较长(比值比1.004,p值<0.001)、湿化高流量鼻导管使用时间较长(比值比1.003,p<0.001)、表面活性剂剂量(比值比1.55,p值0.038)以及接受产后类固醇治疗(比值比19.03,p<0.001)。在合并症、管理、并发症、住院次数或至矫正年龄12个月时的体重方面,没有其他显著差异。
原住民婴儿患慢性新生儿肺病的产前风险因素增加,且病例数占比过高,然而,他们至矫正年龄12个月时的结局与非原住民婴儿相似。